comparemela.com

Egilsk Bogdanovics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investigational Approaches for Treating T1D

Schafer Boeder, MD, and Egils K. Bogdanovics, MD, share approaches to prevention, preservation, and replacement therapies for the treatment of T1D.

New yorkUnited statesSchafer boederEgilsk bogdanovicsSteve edelmanNew york timesWall street journalType 1 diabetesImmunosuppression therapyPluripotent stem cells

Bridging the Gap for T1D Management

Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.

Egilsk bogdanovicsSteve edelmanJustinm gregoryLindaa dimeglioSchafer boederPeer exchangeType 1 diabetesChild insulin needs

Long-Term Monitoring of Teplizumab in T1D

Long-Term Monitoring of Teplizumab in T1D
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Justinm gregorySteve edelmanEgilsk bogdanovicsLindaa dimeglio

Efficacy of Teplizumab in Clinical Trials

Egils K. Bogdanovics, MD, and the expert panel review the TN10 study data on the efficacy of teplizumab in delaying the progression of T1D, which led to the drug’s approval from the FDA.

Lindaa dimeglioSteve edelmanEmily simsEgilsk bogdanovicsJustinm gregorySchafer boederType 1 diabetesTn10 study

T1D Screening Options

Linda A. DiMeglio, MD, reviews screening options for patients with a family history of T1D, highlighting TrialNet.

Lindaa dimeglioSteve edelmanEgilsk bogdanovicsSchafer boederHispanic whiteType 1 diabetesAntibody screening

vimarsana © 2020. All Rights Reserved.